Literature DB >> 35891747

Investigation on the Association of Cardiovascular Markers with Severity of Chronic Pyelonephritis.

O A Efremova1, L A Kamyshnikova1, S E Veysalov1, M S Sviridova1, N I Obolonkova1, M A Gayvoronskaya1, M Wuraola1.   

Abstract

Chronic kidney disease (CKD) is an established independent risk factor for cardiovascular disease (CVD) and is caused by chronic pyelonephritis (CP). This study aimed to investigate the effect of the association of cardiovascular markers with the course of CP on the comorbidity of CP with ischemic heart disease. The study participants included 125 patients with CP without symptoms of urinary tract obstruction who were divided into three groups. The first group (n=45) consisted of patients with recurrent CP (CPr) three or more times per year. The second group (n=42) included patients with active phase pyelonephritis (CPa), with a frequency of two times or less per year, with concomitant pathology (stable coronary artery disease, functional class I - II), and the third group (n=38) included patients with an inactive phase of the disease (CPi), with a history of pyelonephritis of at least five years. The patients' carotid artery augmentation index (AI %) and the change in the diameter of the brachial artery (D %) in CPi, CPa, and CPr groups were 8.44±1.76, 15.47±4.00, 11.71±1.70, 13.81±3.06, 12.75±2.55 and 6.54±3.27, respectively. The left ventricular ejection fraction (EF) index in the three study groups was estimated to be 68.92±3.76, 64.76±2.75, and 66.28±3.45%, respectively. An analysis of the results showed the most significant changes in the parameters of the cardiovascular system in patients with a comorbid and relapsing course of CP. The results showed a significant increase in pulmonary artery diameter, EF, left ventricular pressure and volume, pulse wave velocity in the aorta, and vascular resistance index.

Entities:  

Keywords:  Chronic pyelonephritis; Echocardiography; Great vessels; Structural-functional state

Mesh:

Year:  2022        PMID: 35891747      PMCID: PMC9288603          DOI: 10.22092/ARI.2021.356614.1883

Source DB:  PubMed          Journal:  Arch Razi Inst        ISSN: 0365-3439


  19 in total

Review 1.  Causal Connections From Chronic Kidney Disease to Cardiac Fibrosis.

Authors:  Melanie S Hulshoff; Sandip K Rath; Xingbo Xu; Michael Zeisberg; Elisabeth M Zeisberg
Journal:  Semin Nephrol       Date:  2018-11       Impact factor: 5.299

Review 2.  Principles of exercising in patients with chronic kidney disease, on dialysis and for kidney transplant recipients.

Authors:  I Fuhrmann; R Krause
Journal:  Clin Nephrol       Date:  2004-05       Impact factor: 0.975

3.  Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease.

Authors:  Miklos Z Molnar; Kamyar Kalantar-Zadeh; Evan H Lott; Jun Ling Lu; Sandra M Malakauskas; Jennie Z Ma; Darryl L Quarles; Csaba P Kovesdy
Journal:  J Am Coll Cardiol       Date:  2013-11-21       Impact factor: 24.094

4.  Kidney disease and increased mortality risk in type 2 diabetes.

Authors:  Maryam Afkarian; Michael C Sachs; Bryan Kestenbaum; Irl B Hirsch; Katherine R Tuttle; Jonathan Himmelfarb; Ian H de Boer
Journal:  J Am Soc Nephrol       Date:  2013-01-29       Impact factor: 10.121

Review 5.  Acute kidney injury.

Authors:  John A Kellum; Paola Romagnani; Gloria Ashuntantang; Claudio Ronco; Alexander Zarbock; Hans-Joachim Anders
Journal:  Nat Rev Dis Primers       Date:  2021-07-15       Impact factor: 52.329

6.  Uremic toxicity and sclerostin in chronic kidney disease patients.

Authors:  Lucie Desjardins; Sophie Liabeuf; Rodriguo B Oliveira; Loïc Louvet; Saïd Kamel; Horst-Dieter Lemke; Raymond Vanholder; Gabriel Choukroun; Ziad A Massy
Journal:  Nephrol Ther       Date:  2014-07-26       Impact factor: 0.722

Review 7.  Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease.

Authors:  Hamid Moradi; Domenic A Sica; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2013-08-06       Impact factor: 3.754

Review 8.  Obesity, hypertension, and chronic kidney disease.

Authors:  Michael E Hall; Jussara M do Carmo; Alexandre A da Silva; Luis A Juncos; Zhen Wang; John E Hall
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-02-18

9.  Constipation and the Quality of Life in Conservatively Treated Chronic Kidney Disease Patients: A Cross-sectional Study.

Authors:  Jakub Ruszkowski; Zbigniew Heleniak; Ewa Król; Agnieszka Tarasewicz; Joanna Gałgowska; Jacek M Witkowski; Alicja Dębska-Ślizień
Journal:  Int J Med Sci       Date:  2020-10-18       Impact factor: 3.738

10.  Cardiac biomarkers in chronic kidney disease are independently associated with myocardial edema and diffuse fibrosis by cardiovascular magnetic resonance.

Authors:  Luca Arcari; Juergen Engel; Tilo Freiwald; Hui Zhou; Hafisyatul Zainal; Monika Gawor; Stefan Buettner; Helmut Geiger; Ingeborg Hauser; Eike Nagel; Valentina O Puntmann
Journal:  J Cardiovasc Magn Reson       Date:  2021-06-07       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.